OPKO Health EBITDA Margin 2010-2024 | OPK
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for OPKO Health (OPK) over the last 10 years. The current EBITDA margin for OPKO Health as of September 30, 2024 is .
| OPKO Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $0.71B | $-0.09B | -12.08% |
| 2024-06-30 | $0.72B | $-0.16B | -22.73% |
| 2024-03-31 | $0.80B | $-0.09B | -11.50% |
| 2023-12-31 | $0.86B | $-0.05B | -5.90% |
| 2023-09-30 | $0.87B | $-0.04B | -4.27% |
| 2023-06-30 | $0.87B | $-0.06B | -6.91% |
| 2023-03-31 | $0.91B | $-0.08B | -8.32% |
| 2022-12-31 | $1.00B | $-0.12B | -11.55% |
| 2022-09-30 | $1.22B | $-0.13B | -10.74% |
| 2022-06-30 | $1.43B | $-0.01B | -0.91% |
| 2022-03-31 | $1.56B | $-0.00B | -0.32% |
| 2021-12-31 | $1.77B | $0.10B | 5.52% |
| 2021-09-30 | $1.87B | $0.21B | 11.35% |
| 2021-06-30 | $1.91B | $0.20B | 10.37% |
| 2021-03-31 | $1.77B | $0.22B | 12.55% |
| 2020-12-31 | $1.44B | $0.14B | 10.03% |
| 2020-09-30 | $1.16B | $-0.02B | -1.29% |
| 2020-06-30 | $0.97B | $-0.07B | -7.56% |
| 2020-03-31 | $0.89B | $-0.15B | -16.52% |
| 2019-12-31 | $0.90B | $-0.18B | -19.87% |
| 2019-09-30 | $0.90B | $-0.16B | -17.35% |
| 2019-06-30 | $0.92B | $-0.15B | -16.30% |
| 2019-03-31 | $0.96B | $-0.11B | -11.06% |
| 2018-12-31 | $0.99B | $-0.07B | -7.37% |
| 2018-09-30 | $0.93B | $-0.14B | -14.95% |
| 2018-06-30 | $0.93B | $-0.15B | -16.41% |
| 2018-03-31 | $0.96B | $-0.17B | -18.01% |
| 2017-12-31 | $0.97B | $-0.17B | -17.91% |
| 2017-09-30 | $0.98B | $-0.09B | -9.32% |
| 2017-06-30 | $1.03B | $-0.07B | -6.52% |
| 2017-03-31 | $1.09B | $-0.01B | -1.28% |
| 2016-12-31 | $1.12B | 0 | 0.00% |
| 2016-09-30 | $1.22B | $0.06B | 5.24% |
| 2016-06-30 | $1.07B | $0.07B | 6.19% |
| 2016-03-31 | $0.75B | $-0.01B | -1.06% |
| 2015-12-31 | $0.49B | $-0.06B | -11.41% |
| 2015-09-30 | $0.24B | $-0.10B | -41.08% |
| 2015-06-30 | $0.12B | $-0.15B | -124.58% |
| 2015-03-31 | $0.10B | $-0.16B | -155.00% |
| 2014-12-31 | $0.09B | $-0.13B | -140.22% |
| 2014-09-30 | $0.09B | $-0.13B | -150.57% |
| 2014-06-30 | $0.09B | $-0.10B | -115.91% |
| 2014-03-31 | $0.09B | $-0.09B | -98.86% |
| 2013-12-31 | $0.10B | $-0.06B | -64.95% |
| 2013-09-30 | $0.09B | $-0.04B | -42.39% |
| 2013-06-30 | $0.08B | $-0.03B | -37.35% |
| 2013-03-31 | $0.07B | $-0.02B | -34.78% |
| 2012-12-31 | $0.05B | $-0.03B | -59.57% |
| 2012-09-30 | $0.04B | $-0.03B | -78.38% |
| 2012-06-30 | $0.03B | $-0.03B | -84.38% |
| 2012-03-31 | $0.03B | $-0.02B | -80.00% |
| 2011-12-31 | $0.03B | $-0.02B | -71.43% |
| 2011-09-30 | $0.03B | $-0.01B | -31.03% |
| 2011-06-30 | $0.03B | $-0.01B | -28.57% |
| 2011-03-31 | $0.03B | $-0.01B | -33.33% |
| 2010-12-31 | $0.03B | $-0.01B | -32.14% |
| 2010-09-30 | $0.02B | $-0.02B | -78.95% |
| 2010-06-30 | $0.02B | $-0.02B | -106.67% |
| 2010-03-31 | $0.01B | $-0.02B | -160.00% |
| 2009-12-31 | $0.00B | $-0.02B | -525.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.078B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $196.322B | 23.95 |
| Intuitive Surgical (ISRG) | United States | $195.140B | 102.02 |
| Alcon (ALC) | Switzerland | $42.414B | 28.38 |
| Edwards Lifesciences (EW) | United States | $41.569B | 26.40 |
| IQVIA Holdings (IQV) | United States | $36.630B | 20.18 |
| IDEXX Laboratories (IDXX) | United States | $34.166B | 40.24 |
| DexCom (DXCM) | United States | $28.447B | 42.84 |
| Waters (WAT) | United States | $22.175B | 32.79 |
| STERIS (STE) | Ireland | $21.157B | 24.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.795B | 0.00 |
| Hologic (HOLX) | United States | $18.343B | 19.35 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.004B | 13.35 |
| Sysmex ADR (SSMXY) | Japan | $12.946B | 0.00 |
| Globus Medical (GMED) | United States | $11.536B | 29.21 |
| Penumbra (PEN) | United States | $9.397B | 92.04 |
| Masimo (MASI) | United States | $9.260B | 44.81 |
| Teleflex (TFX) | United States | $8.904B | 14.20 |
| Glaukos (GKOS) | United States | $7.940B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.884B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.632B | 26.26 |
| Veracyte (VCYT) | United States | $3.068B | 92.07 |
| Inari Medical (NARI) | United States | $2.907B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.787B | 16.09 |
| TransMedics (TMDX) | United States | $2.552B | 80.89 |
| Nihon Kohden (NHNKY) | Japan | $2.480B | 18.84 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 17.66 |
| Tandem Diabetes Care (TNDM) | United States | $2.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.820B | 9.51 |
| RxSight (RXST) | United States | $1.807B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.427B | 0.00 |
| Artivion (AORT) | United States | $1.185B | 78.53 |
| Pulse Biosciences (PLSE) | United States | $1.088B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.855B | 14.53 |
| Paragon 28 (FNA) | United States | $0.841B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.723B | 0.00 |
| IRadimed (IRMD) | United States | $0.675B | 36.46 |
| OrthoPediatrics (KIDS) | United States | $0.638B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.593B | 13.97 |
| AxoGen (AXGN) | United States | $0.587B | 0.00 |
| SiBone (SIBN) | United States | $0.527B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.493B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.463B | 31.05 |
| Tactile Systems Technology (TCMD) | United States | $0.428B | 23.18 |
| CVRx (CVRX) | United States | $0.360B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.326B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.312B | 0.00 |
| NeuroPace (NPCE) | United States | $0.290B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.278B | 0.00 |
| Inogen (INGN) | United States | $0.223B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.204B | 0.00 |
| Accuray (ARAY) | United States | $0.194B | 0.00 |
| Nevro (NVRO) | United States | $0.169B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.162B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.146B | 15.60 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| LENSAR (LNSR) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
| Hyperfine (HYPR) | United States | $0.074B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.068B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
| Envoy Medical (COCH) | United States | $0.044B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.041B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Neuronetics (STIM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Spectral AI (MDAI) | United States | $0.022B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |